Medicina
Facultad
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan–Ann Arbor (128)
2024
-
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study
Future oncology (London, England), Vol. 20, Núm. 6, pp. 297-306
-
Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease
Biomedicines, Vol. 12, Núm. 2
2023
-
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
PLoS ONE, Vol. 18, Núm. 1 January
-
Potential pitfalls in the use of real-world data for studying long COVID
Nature Medicine
-
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003
-
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7
2022
-
Artificial intelligence analysis of the impact of fibrosis in arrhythmogenesis and drug response
Frontiers in Physiology, Vol. 13
-
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
The Lancet Haematology, Vol. 9, Núm. 1, pp. e14-e25
-
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality
npj Digital Medicine, Vol. 5, Núm. 1
-
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Nature Medicine, Vol. 28, Núm. 8, pp. 1640-1645
-
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
Nature communications, Vol. 13, Núm. 1, pp. 1878
-
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Annals of Oncology, Vol. 33, Núm. 11, pp. 1168-1178
-
Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome
Cardiovascular research, Vol. 118, Núm. 4, pp. 1046-1060
2021
-
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
New England Journal of Medicine, Vol. 385, Núm. 25, pp. 2336-2347
-
Autophagy in major human diseases
EMBO Journal, Vol. 40, Núm. 19
-
Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations
Journal of Neurotrauma, Vol. 38, Núm. 18, pp. 2514-2529
-
Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value
Frontiers in Physiology, Vol. 12
-
Exercise Interventions to Prevent and Improve Sarcopenia
Sarcopenia: Second Edition (wiley), pp. 305-333
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Modified full-face snorkel masks as reusable personal protective equipment for hospital personnel
PLoS ONE, Vol. 16, Núm. 1 January